GGrantIndex
Sort

17,828 grants matching crispr

Maintenance and expansion of long-term hematopoietic stem cells

$540,335
Peter S Klein · University Of Pennsylvania · R01 · FY2021 · HL

Maintenance and expansion of long-term hematopoietic stem cells

$540,335
Peter S Klein · University Of Pennsylvania · R01 · FY2018 · HL

Maintenance and expansion of long-term hematopoietic stem cells

$540,335
Peter S Klein · University Of Pennsylvania · R01 · FY2019 · HL

Project 4: Transcriptional Coactivators and Enhancers in Human Cancer

$540,262
Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2022 · CA

Genetics and Pathobiology of Disorders of Keratinization

$540,185
Keith A Choate · Yale University · R01 · FY2025 · AR

Mapping the Pharmacogenetic Landscape for Precision Medicine

$540,138
Alan Ashworth · University Of California, San Francisco · U54 · FY2020 · CA

mRNA stability and its impact on hematopoiesis and acute leukemia

$540,134
Iannis Aifantis · New York University School Of Medicine · R01 · FY2025 · CA

mRNA stability and its impact on hematopoiesis and acute leukemia

$540,134
Iannis Aifantis · New York University School Of Medicine · R01 · FY2022 · CA

Epigenetic analysis of osteosarcoma to define subclasses relevant to chemoresistance and metastasis

$540,090
Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2025 · CA

Targeting the orphan nuclear receptor LRH-1 with small molecules

$540,008
Eric A Ortlund · Emory University · R01 · FY2025 · DK

Bromodomain and extra-terminal motif (BET) inhibitors in Solitary fibrous tumor (SFT)

$539,911
Leonidas Bleris · University Of Texas Dallas · R01 · FY2024 · CA

Mechanisms of motor superperformance

$539,677
Juan M. Pascual · Ut Southwestern Medical Center · R56 · FY2022 · NS

Mechanisms of epithelial repair and remodeling in pulmonary fibrosis

$539,643
Jonathan Andrew Kropski · Vanderbilt University Medical Center · R01 · FY2024 · HL

Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis

$539,556
Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R35 · FY2017 · GM

Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma

$539,540
Keith D Robertson · Mayo Clinic Rochester · R01 · FY2025 · CA

Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox

$539,425
E. John Wherry · University Of Pennsylvania · R01 · FY2020 · AI

Cis Regulatory Elements and Systemic Lupus Erythematosus

$539,330
Joseph E Craft · Yale University · R01 · FY2017 · AR

Cis Regulatory Elements and Systemic Lupus Erythematosus

$539,330
Joseph E Craft · Yale University · R01 · FY2018 · AR

Cis Regulatory Elements and Systemic Lupus Erythematosus

$539,330
Joseph E Craft · Yale University · R01 · FY2016 · AR

The regulation of thrombopoietin levels

$539,293
Rami Khoriaty · University Of Michigan At Ann Arbor · R01 · FY2022 · HL

The regulation of thrombopoietin levels

$539,293
Rami Khoriaty · University Of Michigan At Ann Arbor · R01 · FY2021 · HL

The regulation of thrombopoietin levels

$539,293
Rami Khoriaty · University Of Michigan At Ann Arbor · R01 · FY2023 · HL

Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect

$539,158
Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL

Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer

$538,965
Peter Kent Jackson · Stanford University · U01 · FY2019 · CA

Effect of senescent cells

$538,963
Stephen C Jameson · University Of Minnesota · P01 · FY2025 · AI